Peptides, explained the way you wish someone had explained them.

Drives blood flow to injured tendon, ligament, and gut tissue. People run it for nagging joint and tendon injuries and for gut issues.

Drives healing and recovery system-wide rather than at one spot — tendon, ligament, muscle, and the inflammation that tags along with an injury. People run it for the same nagging injuries as BPC-157, but reach for it when the problem is diffuse or hard to pin a needle near.

On the skin, people run it for firmness, fine lines, wound and scar healing, and overall skin quality — it’s one of the most-used ingredients in serious cosmetic chemistry. Injected, the community reaches for it as a repair and anti-aging signal: skin and hair quality, faster healing, and a long tail of anecdotal claims (hair regrowth, even gray-hair reversal) that the evidence does not back. The split matters: the topical use is the studied one.

Applied to the skin — forehead, crow’s-feet, frown lines — it’s proposed to relax the tiny repeated muscle contractions that etch dynamic wrinkles, so lines look a little softer over weeks of twice-daily use. The honest framing: the effect is subtle and surface-level. This is a cosmetic ingredient, not an injectable and not a drug.

People run it for nerve pain and small-fiber neuropathy — the burning, tingling, pins-and-needles kind — and for general anti-inflammatory tissue protection. The specific conditions it was actually trialed in are narrow: small-fiber neuropathy tied to sarcoidosis, and painful neuropathy in type-2 diabetes. The reported draw is calmer nerves and, in the diabetes trial, some improvement in metabolic markers alongside the nerve effects.

Prompts your pituitary to release a pulse of your own growth hormone, rather than injecting GH itself. People run it for sleep — by far the loudest reported benefit — along with recovery, lean mass, and the slow body-recomposition that comes with raised GH/IGF-1.

Increases how much growth hormone your pituitary releases per pulse. On its own it raises baseline GH; paired with Ipamorelin (which triggers the pulses) it’s the standard at-home GH stack. People run it for sleep, recovery, lean mass, and the gradual body-recomposition of raised GH/IGF-1.

People run it for one thing: fat loss — faster, and more of it, than anything else in the class. The standout reported effects are heavy appetite suppression and a sharp drop in “food noise,” plus visceral- and liver-fat reduction. It's the rare peptide here with real Phase-2 trial data behind the exact use people run it for.

People run it for fat loss, steadier energy, and better insulin sensitivity — a metabolic “tune-up,” especially for anyone feeling the early slide into insulin resistance with age. The reported wins are improved glucose handling, easier fat-burning, and less afternoon crash. It is not an appetite drug: unlike the GLP-1 class, it works by helping cells use fuel, not by shutting down hunger.

People run it for muscle growth and recovery — the loudest claim is hyperplasia (growing new muscle cells, not just enlarging existing ones), alongside nutrient partitioning and "building while leaning out." Be clear about what's underneath that: there are essentially no human trials of this analog for any of these uses. What you're reading from the community is belief and lived report, not data.

People run it for two things: weight loss and blood-sugar control. The standout reported effect is heavy appetite suppression and a sharp drop in “food noise” — the constant background pull toward eating. It’s the rare peptide here with large Phase-3 trials behind the exact uses people run it for, including a roughly 15% average body-weight loss at ~68 weeks in non-diabetic adults.

People run it for fat loss and, in the diabetic world, for blood-sugar control — and it delivers both hard. The standout reported effects are strong appetite suppression and a sharp drop in “food noise,” with trial weight loss landing between the single-receptor drugs and the triple agonist. Unlike most peptides on this site, the use people run it for is the use it was actually trialed and approved for.

People run it for fat loss, the same goal as the GLP-1 drugs — but it gets there through amylin rather than GLP-1, so the felt experience is described as a steadier, more “full and satisfied” fullness than the sharp food-noise shutoff of semaglutide or tirzepatide. Solo it’s a moderate-strength weight-loss shot. Its real draw is as the partner peptide: pair it with a GLP-1 and the two appetite systems add together.

People run it for fat loss, with two reported signatures the rest of the GLP-1 class is quieter on: a metabolic-rate lift from the glucagon arm, and a strong pull on liver fat. The usual appetite suppression and “food noise” drop are there too. It’s one of the few peptides here with real Phase-2 and Phase-3 trial data for the exact use people run it for — but almost all of that data is in Chinese adults.

People run it for fat loss — strong appetite suppression and the same drop in “food noise” the rest of the GLP-1 class is known for, with weight loss landing between the single-receptor drugs and the triple agonist. The quieter reason it gets attention is the liver: it’s studied specifically for MASH (metabolic dysfunction-associated steatohepatitis, the inflammatory end of fatty-liver disease), where it cleared the disease without worsening scarring in a majority of trial patients at the higher dose.

People run it for one thing above all: visceral, deep-abdominal fat — the hard, around-the-organs gut fat, not the pinchable subcutaneous kind. The GH/IGF-1 bump that comes with it brings the usual secondary draws (sleep, recovery, body recomposition), but the standout, and the reason it has trials at all, is the drop in visceral fat measured on CT scans.

Prompts your pituitary to release its own growth hormone in natural pulses, rather than injecting GH itself. It raises how much GH each pulse puts out — the same GHRH lever CJC-1295 pulls. People run it for sleep, recovery, and the slow body-recomposition of gently raised GH/IGF-1, and reach for it as the more conservative, better-documented option in the GH-secretagogue family.

Prompts your pituitary to release a pulse of your own growth hormone rather than injecting GH itself. People run it for the same reasons as Ipamorelin — sleep, recovery, lean mass, slow recomposition — but reach for GHRP-2 when they want a stronger kick and are willing to accept the messier hormonal fingerprint that comes with it.

Prompts your pituitary to release a pulse of your own growth hormone — the same job as ipamorelin — rather than injecting GH itself. But the effect people actually feel first and loudest is ravenous hunger within 20–30 minutes. Some run it deliberately for that, to drive appetite when bulking or eating is hard; others run it for the GH-side benefits (recovery, lean mass, sleep) and treat the hunger as a tax.

People run it for fat loss — specifically the promise of burning fat without raising growth hormone, IGF-1, or touching blood sugar. The community use is a daily fasted shot as a lean-out adjunct alongside diet and training. Worth saying plainly up front: the human obesity trials that tested exactly this largely failed to outperform placebo, so what people are buying is a mechanism story, not a results story.

People run it for local, site-specific muscle growth — the lore is that you pin it into a lagging body part right after working it, and because it clears so fast it acts where you put it before the blood carries it away. Reported effects are a tight “pump,” localized fullness, and hyperplasia (new muscle cells) in the worked muscle. Be clear about the floor under that: there are essentially no human trials of IGF-1 DES for any of this. What you’re reading is belief and lived report, not data.

People run it for fat loss and a metabolic lift — the pitch is that it lets fat cells burn more and store less without you eating less. In the mouse work that’s exactly what happened: lower body weight and shrinking fat mass with no drop in food intake. Read that honestly, though: it’s a preclinical result in animals, not a proven human effect. Nobody can tell you what it does in a person, because that study hasn’t been done.

Targets the mitochondria themselves — the cell’s power plants — to steady energy (ATP) production and tamp down the oxidative stress that builds up as they age or get damaged. People run it for energy, faster recovery, and as a longevity play, on the theory that better-functioning mitochondria pay off everywhere at once.

People run it for focus and mental clarity, for a calmer baseline mood, and — the reason it has a clinical history at all — for neuroprotection. The most-reported everyday effects are mood/calm and cognition; the neuroprotective use is what Russian medicine actually approved it for.

People run it for sleep quality — not falling asleep faster so much as sleeping deeper and waking more recovered. The most-repeated routine is a small dose before bed to push slow-wave and REM sleep. Worth knowing up front: the human studies behind it are decades old and the sleep effect itself is inconsistent, so this is one of the more faith-based protocols on the site.

People run it for anxiety relief and a clearer head — a takes-the-edge-off calm that, unlike sedatives, isn't supposed to dull you. The most-repeated experience is fast onset: a noticeable settling within minutes to half an hour of a nasal spray, lasting a few hours. Secondary, people report steadier focus and better stress tolerance on busy days.

People run it in cycles for cognition, memory, mental clarity, and recovery — lifting brain fog and sharpening focus is the most-repeated community theme, alongside mood and a sense of faster recovery. Abroad it's used clinically for stroke, traumatic brain injury, and dementia; the community use is a self-directed extension of that.

People run it as an anti-aging cycle — a couple of short courses a year — for the headline promise of telomere maintenance, plus better-regulated sleep and a normalized melatonin rhythm. The most-repeated everyday report is sleep and circadian benefit; the longevity claim is the reason anyone reaches for it, but it’s also the claim the evidence supports least.

People run it for neuroprotection and cognition — the idea is a peptide that helps neurons survive oxidative stress and low oxygen, and over time supports memory and mental clarity. It’s usually framed as a long-game “protect the brain” compound rather than something with a felt, same-day effect, and it’s frequently grouped with other bioregulators in a longevity-style stack.

It’s an opioid analgesic — it kills pain by doing exactly what morphine, fentanyl, and heroin do, only with extreme potency at the receptor. With that pain relief comes the entire opioid liability: respiratory depression (the thing that actually kills people), sedation, tolerance, physical dependence, and addiction. It has no nootropic, longevity, recovery, or “feel-better” use that separates it from any other strong opioid. In the real world its notoriety comes from misuse, not medicine: it surfaced as an illicit doping agent in horse racing around 2011 — given to mask pain so animals would run injured — which is also why most of the modern literature on it is doping-detection methodology, not human therapy.

Modulates — balances — the immune system rather than simply revving it up. People run it for immune resilience: fewer or shorter colds, support through chronic or recurrent infection, and as an adjunct when the immune system is run-down. Worth knowing up front: it’s clinically approved abroad for chronic hepatitis B and C and as a vaccine/immune adjuvant, but the everyday “stay healthy” use most people run is an extrapolation from those disease settings, not something trials directly tested.

People run it to restore or normalize immune function — the pitch is less “boost” than “recalibrate,” nudging a slowing, aging immune system back toward a younger balance. The community uses it for general immune resilience and as a longevity/healthspan layer, often in short seasonal courses rather than continuously.

People run it for stubborn infections — the chronic, biofilm-protected kind that antibiotics struggle with (Lyme and gut dysbiosis come up constantly) — and secondarily for wound healing and general immune modulation. The pitch is a broad-spectrum, your-own-biology antimicrobial that also calms inflammation and nudges tissue repair. Worth stating plainly up front: the way people run it — injected, for systemic infection — has essentially no efficacy trials behind it. The science is enormous but almost entirely lab-dish and animal.

Calms inflammation rather than building or repairing tissue. People run it for gut inflammation — IBD- and IBS-type complaints are the loudest use — for inflammatory skin issues, and as a general anti-inflammatory add-on layered onto a repair stack. It’s taken oral or injected depending on the target.

People run intranasal VIP to dial down inflammation and rebalance an over-active immune system. The headline community use is the chronic inflammatory response syndrome (CIRS / mold-illness) protocol associated with one clinician’s framework, where it’s the last step taken only after everything else is addressed. Outside that, people reach for it for general inflammation and immune balance. Worth knowing up front: VIP is very short-acting, and the strongest real human evidence is in lung conditions (sarcoidosis, pulmonary hypertension) — not the at-home nasal-spray use most people are actually running.

Two completely different uses live under one name. Medically, it’s an injectable hormone given in hospitals to induce or strengthen labor contractions and to control bleeding after delivery — that use is regulatory-approved and not in question. In the community, people spray it up the nose before social or intimate situations, chasing more trust, warmth, lower social anxiety, and better connection during sex. The nasal use is the popular one; it’s also the one the evidence struggles to support.

Triggers the brain to release GnRH, which raises LH and FSH, which in turn raise testosterone (and estrogen). People run it for libido and arousal — the most-reported effect — and as a gentle push on natural testosterone and fertility, since it’s working with your own axis rather than overriding it. The honest catch: the acute hormone bump is well-documented, but the body-comp and libido protocols people actually run are not.

Acts as a stand-in for luteinizing hormone: it binds the LH receptor on the testes’ Leydig cells and drives them to produce testosterone, which also keeps the testes full-sized and functional rather than shrinking. Three real uses sit behind it — treating male hypogonadism and fertility, restoring or maintaining testicular function during and after testosterone or anabolic use (the dominant community reason people run it), and triggering ovulation in female fertility treatment. The honest split: the endocrine and fertility medicine is genuinely established; the exact TRT-adjunct dosing people run alongside testosterone is extrapolated from that, not separately validated.

In its actual medical role it drives the gonads directly: in women it induces ovulation (FSH grows the follicles, the LH activity supports the final maturation), and in men with hypogonadotropic hypogonadism it restores sperm production. The community use is the male-fertility one — people pair it with HCG to rebuild full testicular function. The honest framing up front: the fertility indications are genuinely clinical, but the specific protocols people run to ‘restore fertility’ off-cycle are extrapolated from that clinical use, not validated as their own thing.

Raises sexual desire and arousal centrally — and notably in women as well as men, which is the angle the community returns to most. It’s taken occasionally, ahead of activity, not on a daily schedule.

People run it for one thing: a tan that comes from inside the skin rather than the sun, plus the photoprotection that comes with it. It pushes the skin to produce eumelanin, so users report tanning faster and burning less for the same sun exposure. As a regulated drug it's used for a rare light-sensitivity disease (erythropoietic protoporphyria, EPP) — the community tanning use borrows that biology off-label.

People run it to tan with far less sun — and, very often, for the side effects: spontaneous erections, a libido bump, and blunted appetite. That bundle is the whole point of MT-2 over MT-1. The honest framing up front: it’s unapproved, the human evidence is thin and old, and the case-report harms are not theoretical.

People run it for a cluster of vague-but-appealing goals: more energy, sharper focus, a slowed-down clock (“anti-aging”), and — a big one in this corner — support during addiction and alcohol recovery. The delivery methods are the tell that this is community territory: long IV infusions (often hours, and frequently uncomfortable), SubQ shots, or intranasal spray. What it actually is, though, is not a drug with a target — it’s a coenzyme your cells already use by the billion every second. The leap from “this molecule is essential” to “injecting more of it makes you feel amazing” is exactly the leap the evidence hasn’t made.

Inside the cell it’s the workhorse of redox defense — it neutralizes free radicals and serves as the cofactor that lets the body’s detox enzymes do their job. That’s the real biology. What people actually buy it for is different: antioxidant/anti-aging and liver “detox” support, and — the headline use in much of Asia and increasingly elsewhere — skin lightening (a brighter, more even, lighter complexion). It’s run IV, SubQ, nebulized/inhaled, or oral, depending on which claim someone is chasing.

In true deficiency it does exactly what it’s supposed to: it rebuilds red blood cells, reverses the anemia, and — caught early enough — halts and partly reverses the nerve damage that long-standing deficiency causes. That’s the legitimate use, and it’s not controversial. The popular use is the other one: a B12 shot marketed as an energy, mood, and focus boost for people whose levels are already normal. Those are two completely different claims, and they have very different amounts of evidence behind them.

At normal dietary doses it does the boring, essential thing exceptionally well: it’s the cofactor your body needs to build collagen, so adequacy keeps skin, blood vessels, gums and connective tissue intact — and frank deficiency is scurvy, which is dramatic, real, and completely reversible with vitamin C. It also recycles other antioxidants and helps you absorb iron. None of that is in dispute. What people actually seek it out for — IV drips for ‘immune boosting,’ faster recovery, or as an add-on to cancer care — is a separate and far shakier claim than the textbook biochemistry.

People get it for fat loss — usually as a weekly or twice-weekly injection bundled into a clinic’s diet-and-coaching program, often alongside a GLP-1 or a calorie-restricted plan. What it actually contains is a blend, not a drug: most commonly methionine, inositol, and choline (the “MIC” base), almost always with vitamin B12, and sometimes L-carnitine or other B-vitamins. Said plainly up front: any weight change people see on Lipo-C tracks the diet and program it’s sold alongside, not the injection. The shot is the ritual; the deficit is the mechanism.